Gene therapy for sickle cell disease passes key preclinical test

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.

Computer models provide new understanding of sickle cell disease

David A. Williams, MD - Dana-Farber Cancer Institute

Medical Research for Health Care Professionals - SICKLE CELL ASSOCIATION OF BC

Editor's Pick Archives — Page 33 of 225 — Harvard Gazette

PDF) Editing Human DNA Moral and social implications of germline genetic modification

gene therapy Archives - Page 4 of 5 - Boston Children's Answers

HemaApp screens for anemia, blood conditions without needle sticks

Milwaukee Area Sickle Cell Support Group

Sickle cell gene therapy passes key preclinical test - Boston Children's Answers

Genome engineering paves the way for sickle cell cure

Milwaukee Area Sickle Cell Support Group